Clinical trial Recruiting at 1 site Interventional Ages 18 to 75 Women only

Comparing laser treatment and sclerotherapy for reticular leg veins

Official title: Treatment of Reticular Leg Veins: a Prospective, Randomized, Comparative Clinical Trial of a 1064 nm Nd:YAG Long Pulse Laser, Combined Treatment of a 1064 nm Nd:YAG Long Pulse Laser and Sclerotherapy vs. Sclerotherapy Alone.

Run by Derzhavin Tambov State University · NCT06175754 · Data updated 2026-11-12

This study is testing whether a new laser treatment for reticular leg veins works as well as the traditional sclerotherapy, and it will also look at how patients feel about each option and any side effects they might have.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexWomen only
Enrollment174 (estimated)
SponsorDerzhavin Tambov State University
Academic / other
Locations1 site (Tambov)
StatusRecruiting
StartedOctober 9, 2023
Main results expectedJuly 9, 2025
Study endsDecember 9, 2025
Registry record updatedFebruary 5, 2025
Trial IDNCT06175754 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women over 18 years old with reticular veins who can provide informed consent.

Probably not a fit

Patients with conditions such as diabetes, pregnancy, or certain chronic diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of a 1064 nm long-pulsed Nd:YAG laser treatment for reticular leg veins compared to traditional sclerotherapy. It aims to determine if the laser treatment, either alone or in combination with sclerotherapy, is as effective as sclerotherapy alone while also analyzing the frequency of adverse events associated with each method. The study is designed as a prospective, randomized, comparative clinical trial, which is currently lacking in existing literature. By assessing patient satisfaction and side effects, the study seeks to identify the most advantageous treatment option for reticular leg veins.

Why it matters

Potential benefit: If successful, this study could provide patients with a more effective and safer treatment option for reticular leg veins, potentially reducing adverse effects and improving satisfaction.

How similar studies have gone: While there have been studies comparing laser treatment and sclerotherapy, this specific comparative approach is novel and has not been extensively tested in a prospective, randomized format.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* women over 18
* reticular veins
* signed informed consent to participate in the study

Exclusion Criteria:

* diabetes mellitus
* pregnancy or lactation
* malignant neoplasms
* inability or unwillingness of the patient to wear compression stockings
* hypersensitivity to the polidocanol, cold, sunlight
* concomitant diseases: bronchial asthma, severe liver and kidney disease, acute thrombosis and thrombophlebitis, infection of the skin and/or soft tissues, infectious diseases, arteriosclerosis, diabetic angiopathy, heart defects requiring surgery, fever, toxic hyperthyroidism, obesity, tuberculosis, sepsis, violation of the cellular composition of the blood, all diseases requiring bed rest, heart disease with decompensation phenomena,
* known hereditary thrombophilia.
* period after treatment of alcoholism
* reception of oral contraceptives
* sedentary lifestyle

Where it's running

  • Bukina Oksana Vasilyevna
    Tambov, Russia
    Recruiting

Study contacts

  • Principal investigator: Oksana V Bukina, PhD — Derzhavin Tambov State University
  • Study coordinator: Oksana V Bukina, PhD
  • Email: ovsafonova@yandex.ru
  • Phone: +79051204983

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.